InvestorsHub Logo
Followers 78
Posts 11422
Boards Moderated 0
Alias Born 04/03/2014

Re: buckysherm post# 3611

Sunday, 07/21/2019 7:42:01 PM

Sunday, July 21, 2019 7:42:01 PM

Post# of 3833
Agree - they are ahead of everyone in terms NASH-CX - literally no one is near where they are - no drug with P3 ready and good safety and P2 results.

Question of starting the P3 trial and/or convincing BP about their product so they collaborate or buy them out.

These trials are very long - long period of enrollment and min 48 weeks for efficacy - with many other companies, GLMD, MDGL, VKTX, GILD starting P2/P3 trials, NASH patients have high demand - it is very competitive. I would rather have some BP buy this co, let me make money even if not huge and move on.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent GALT News